Mark Bellomy

Ropes & Gray LLP

Mark W. Bellomy is an IP transactions attorney and advises a wide range of companies, investors and institutions concerning all manner of transactions involving technology and intellectual property, including: research, development and commercialization collaborations; licensing; joint ventures; mergers and acquisitions; information technology and business process outsourcing; technology transfers; supply, distribution and co-promotion relationships; and other strategic commercial transactions.

Mark has extensive experience advising companies in the life sciences, high-technology, health care, private equity, financial services, investment management, and branded product industries with respect to technology and intellectual property-driven transactions.

He also provides clients with strategic advice regarding the creation and management of intellectual property assets, as well as day-to-day commercial and corporate matters. Mark is a patent attorney registered with the United States Patent and Trademark Office, and has experience prosecuting patent applications relating to software, electromechanical devices and consumer goods.

Mark has served as in-house counsel for one of the world’s leading pharmaceutical companies. Prior to attending law school, Mark served as a cavalry officer and scout platoon leader in the United States Army.

EDUCATION :

  • JD, magna cum laude, Harvard Law School, 2000
  • BS (Electrical Engineering), Distinguished Cadet, United States Military Academy at West Point, 1994; Phi Kappa Phi; Eta Kappa Nu

ADMISSIONS :

  • U.S. Patent and Trademark Office, 2002
  • Massachusetts, 2001

MEMBERSHIP & AFFILIATIONS :

  • Licensing Executives Society
  • American Intellectual Property Law Association
  • American Bar Association
  • Massachusetts Bar Association
  • Boston Bar Association

PROFESSIONAL & CIVIC ACTIVITIES :

  • Former co-chair of the Boston Bar Association Intellectual Property Section’s Life Sciences Committee
  • Speaker, intellectual property, licensing and strategic collaboration matters, including presentations for the Association of Corporate Counsel, Massachusetts Biotechnology Council, Boston Bar Association, Massachusetts Continuing Legal Education, and Practising Law Institute.

Experience :

  • Represented Pfizer in its collaboration with Merck KGaA to develop and commercialize anti-PD-L1 antibodies to treat tumors. This transaction won the LES 2015 “Deal of Distinction Award” for the life sciences sector. It included an upfront payment to Merck of $850 million and $2 billion in regulatory and commercial milestones.
  • Represented Pfizer in its strategic licensing agreement with MedGenesis Therapeutix, granting Pfizer an exclusive worldwide option to license MedGenesis’ glial cell line-derived neurotrophic factor (GDNF) protein and convection enhanced delivery (CED) technology to be used in research for potential treatments for Parkinson’s disease.
  • Represented AstraZeneca in its worldwide licensing and partnership agreement with Eolas Therapeutics for the development and commercialization of Eolas’ Orexin-1 Receptor Antagonist program for smoking cessation and other indications.
  • Represented Genzyme in connection with its collaboration agreement and $700 million equity investment in Alnylam Pharmaceuticals related to rare disease siRNA drug candidates.
  • Represented Wyeth in its worldwide licensing, development and supply agreement with Catalent Pharma Solutions for Advil Liqui-Gels®.
  • Represented leading pharmaceutical, medical device and medical technology companies in the development and implementation of licensing and collaboration best practices programs.
  • Represented Pfizer in connection with the reconciliation and integration of collaborative development programs acquired in connection with Pfizer’s acquisition of Wyeth and King Pharmaceuticals.
  • Represented Becton Dickinson in connection with the divestiture of its vertebral augmentation solutions business to Stryker.
  • Represented State Street in connection with information technology and intellectual property matters associated with its acquisition of GE Asset Management from GE.
  • Represented Pfizer, Senju Pharmaceutical Co., Wyeth and other pioneer pharmaceutical companies in the settlement of ANDA litigations.

Cost

Rate : $$$

What types of cases Attorney Mark Bellomy & Ropes & Gray LLP can handle?
Ropes & Gray LLP can handle cases related to laws concerning Business, Health Care, Intellectual Property, Licensing, Trademark infringement. We manually verify each attorney’s practice areas before approving their profiles and reviews on our website.
Where is Ropes & Gray LLP located?
Ropes & Gray LLP is located at Prudential Tower, 800 Boylston St, Boston, MA 02199, USA. You can reach out to Ropes & Gray LLP using their phone line 617.951.7823. You can also check their website ropesgray.com or email them at [email protected].
How much would it cost to hire Ropes & Gray LLP?
Mark Bellomy lawyer charges are specific to each case. However, they work with contingency fees and its ranges from $$ to $$$. They also provide free consultation [and no obligation quotes] if you are interested to hire.
Are Mark Bellomy reviews trust-able?
We have the ratings and reviews moderation team who checks and verifies every review submitted on our website manually. You can trust all the reviews you see on Mark Bellomy lawyer profile listing.

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
Ropes & Gray LLP
Boylston Street 800
Boston 02199 MA US
Get directions

Brian Orlow

0.0
Main Street 71-18
11367 NY US
Advertisement

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement